Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-20 Purchase |
2023-03-22 4:01 pm |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
10,000 | $2.5 | $25,000 | 22,721 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-31 Tax Withholding |
2025-04-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
8,828 | $1.58 | 135,501 (Direct) |
View |
2025-01-21 Option Award |
2025-01-23 4:15 pm |
N/A 2035-01-20 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
230,000 | $0 | 230,000 (Direct) |
View |
2024-12-31 Tax Withholding |
2025-01-02 5:45 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
4,697 | $3.35 | 144,329 (Direct) |
View |
2024-09-30 Tax Withholding |
2024-10-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
105 | $1.88 | 149,026 (Direct) |
View |
2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
143 | $1.92 | 149,131 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:04 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
161 | $3.08 | 149,274 (Direct) |
View |
2024-01-01 Option Award |
2024-01-03 5:20 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
62,500 | $0 | 211,935 (Direct) |
View |
2024-01-02 Tax Withholding |
2024-01-03 5:20 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
161 | $2.28 | 211,935 (Direct) |
View |
2023-12-13 Option Award |
2023-12-15 5:09 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
62,500 | $0 | 149,596 (Direct) |
View |
2023-10-02 Tax Withholding |
2023-10-04 4:21 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,154 | $3.83 | 24,596 (Direct) |
View |
2023-06-30 Tax Withholding |
2023-07-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
157 | $4.1 | 25,750 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:34 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,664 | $3.4563 | 25,907 (Direct) |
View |
2023-03-31 Tax Withholding |
2023-04-04 5:03 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
478 | $3.08 | 22,243 (Direct) |
View |
2022-12-31 Tax Withholding |
2023-01-04 5:12 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.15 | 229,144 (Direct) |
View |
2022-09-30 Tax Withholding |
2022-10-04 5:04 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.223 | 230,957 (Direct) |
View |
2022-06-30 Tax Withholding |
2022-07-05 5:00 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.389 | 232,770 (Direct) |
View |
2022-06-03 Option Award |
2022-06-07 5:36 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director |
30,000 | $0 | 30,000 (Direct) |
View |
2022-03-31 Tax Withholding |
2022-04-04 5:09 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,630 | $0.65 | 234,583 (Direct) |
View |
2022-03-17 Option Award |
2022-03-18 5:09 pm |
N/A 2032-03-17 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
75,000 | $0 | 313,213 (Direct) |
View |
2021-12-31 Tax Withholding |
2022-01-04 4:40 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,484 | $1.02 | 163,213 (Direct) |
View |
2021-10-11 Option Award |
2021-10-12 5:17 pm |
N/A 2031-10-11 |
Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-09-30 Tax Withholding |
2021-10-01 5:11 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,484 | $1.39 | 164,697 (Direct) |
View |
2021-09-02 Option Award |
2021-09-03 5:34 pm |
N/A 2031-09-02 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
121,719 | $0 | 227,041 (Direct) |
View |
2021-06-30 Tax Withholding |
2021-07-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,551 | $3.51 | 105,322 (Direct) |
View |
2021-03-31 Tax Withholding |
2021-04-02 12:14 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,765 | $6.84 | 108,873 (Direct) |
View |
2021-02-22 Option Award |
2021-02-24 4:38 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
97,375 | $0 | 178,800 (Direct) |
View |
2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.58 | 325,703 (Direct) |
View |
2020-11-30 Option Award |
2020-12-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
10,460 | $1.445 | 327,525 (Direct) |
View |
2020-09-30 Tax Withholding |
2020-10-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.66 | 317,065 (Direct) |
View |
2020-06-30 Tax Withholding |
2020-07-02 4:24 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.73 | 318,887 (Direct) |
View |
2020-05-06 Option Award |
2020-05-08 5:53 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC |
150,000 | $0 | 470,712 (Direct) |
View |